Congenital cyanotic heart disease.

Congenital cyanotic heart disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Congenital cyanotic heart disease. Abstract Text:

R C BROCK,R C BROCK,R C BROCK,

Congenital cyanotic heart disease.

Congenital cyanotic heart disease. Publishing Authors By Initials

RC BROCK,RC BROCK,RC BROCK,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Congenital cyanotic heart disease. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Irish journal of medical science

VOLUME: 35

Page Numbers: 305-14

Journal Abbreviation:

ISSN: 0021-1265

DAY: 27

MONTH: Jul

YEAR: 1949

Congenital cyanotic heart disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7806865

Congenital cyanotic heart disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Congenital cyanotic heart disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Congenital cyanotic heart disease.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ir J Med Sci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Congenital cyanotic heart disease Related Publications

• A case series of HIV-positive patients with malignant melanoma.
• A general methodology for the synthesis of transition metal pnictide nanoparticles from pnictate precursors and its application to iron-phosphorus phases.
• An HIV-associated mediastinal germ cell tumour complicated by acute myeloid leukaemia.
• An artificial mitochondrial tail signal/anchor sequence confirms a requirement for moderate hydrophobicity for targeting.
• An improved system for the generation and analysis of mutant proteins containing unnatural amino acids in Saccharomyces cerevisiae.
• An unexpected co-crystal with a variable degree of order: 1:1 rac-1,2-cyclohexanediol/triphenylphosphine oxide.
• Congenital cyanotic heart disease.
• Contact surface and material nonlinearity modeling of human lungs.
• Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications.
• Drainage, streptomycin and tuberculosis.
• Evaluation of hunter-harvested white-tailed deer for evidence of bovine viral diarrhea virus infection in Alabama.
• Expression of 5-lipoxygenase in specialized epithelial cells of nasopharyngeal-associated lymphoid tissue.
• First stage approximation of the exstrophic bladder in patients with cloacal exstrophy--should this be the initial surgical approach in all patients?
• HOW THE CONFEDERATE ARMY WAS VACCINATED.
• Leukotrienes: mediators that have been typecast as villains.
• Malnutrition in South Africa.
• Morbus coeruleus; a study of 50 cases after the Blalock-Taussig operation.
• Particle-rod hybrids: growth of arachidic acid molecular rods from capped cadmium selenide nanoparticles.
• Potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR.
• Surgical outcomes and patient satisfaction after dermal, pericardial, and small intestinal submucosal grafting for Peyronie's disease.
• Synthesis of MnP nanocrystals by treatment of metal carbonyl complexes with phosphines: a new, versatile route to nanoscale transition metal phosphides.
• The activity of lipopeptide TLR2 agonists critically depends on the presence of solubilizers.
• The impact of a fellowship on resident training in an academic pediatric urology practice.
• The role of patients' expectations and goals in the behavioral and pharmacological treatment of obesity.
• The surgery of pulmonary stenosis.
• The surgery of the heart.
• Transcriptional interference: an unexpected layer of complexity in gene regulation.
• [Not Available.]
• [Not Available.]
• miRNA: the new gene silencer.